Inactive Instrument

Diaxonhit Share Price Euronext Paris

Equities

FR0004054427

Biotechnology & Medical Research

Financials

Sales 2023 * 131M 140M 11.19B Sales 2024 * 138M 148M 11.82B Capitalization 146M 156M 12.51B
Net income 2023 * 6M 6.42M 514M Net income 2024 * 9M 9.62M 771M EV / Sales 2023 * 1.19 x
Net Debt 2023 * 8.8M 9.41M 754M Net cash position 2024 * 9.9M 10.59M 848M EV / Sales 2024 * 0.99 x
P/E ratio 2023 *
33.2 x
P/E ratio 2024 *
15 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 59.14%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 18/06/17
Director of Finance/CFO 43 30/09/22
Chief Operating Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - 18/06/17
Director/Board Member 68 03/11/09
Director/Board Member 67 14/06/17
More insiders
Eurobio Scientific is a key player in the field of specialty in vitro diagnostics. It is involved from research to manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, Eurobio Scientific has established its own distribution network and a portfolio of proprietary products in the molecular biology field. The group has approximately 286 employees, three production units based in the Paris region, in Germany and in the United States, and subsidiaries in Dorking in the United Kingdom, Sissach in Switzerland, Bünde in Germany and Utrecht in the Netherlands.
Calendar
More about the company